Cue Biopharma
CUE • NASDAQ
Cue Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Usman Azam, with a market cap of $28.8M.
CEOUsman Azam
Market Cap$28.8M
Biotechnology
Healthcare
Employees53.0
Websitecuebiopharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cue Biopharma
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.10
Revenue Estimate
$2.1M
Earnings History
Past 12 earnings reports for Cue Biopharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.07Est: -$0.09 | +22.2% | $2.1MEst: $2.4M | -9.5% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.09Est: -$0.13 | +30.8% | $3.0MEst: $2.0M | +47.7% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.17Est: -$0.12 | -41.7% | $421.0KEst: $901.5K | -53.3% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.13Est: -$0.14 | +7.1% | $1.6MEst: $1.7M | -7.3% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.17Est: -$0.19 | +10.5% | $3.3MEst: $1.5M | +119.5% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.20Est: -$0.29 | +31.0% | $2.7MEst: $1.3M | +106.0% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.25Est: -$0.28 | +10.7% | $1.7MEst: $1.2M | +41.9% | 10-Q |
| Apr 8, 2024 | Q4 2023 | -$0.28Est: -$0.28 | 0.0% | $1.8MEst: $1.7M | +6.5% | — |
| Nov 3, 2023 | Q3 2023 | -$0.24Est: -$0.34 | +29.4% | $2.1MEst: $1.1M | +85.8% | — |
| Aug 9, 2023 | Q2 2023 | -$0.29Est: -$0.30 | +3.3% | $1.4MEst: $1.2M | +14.2% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.29Est: -$0.29 | 0.0% | $187.0KEst: $2.0M | -90.4% | 10-Q |
| Mar 21, 2023 | Q4 2022 | -$0.37Est: -$0.31 | -19.4% | $151.0KEst: $100.0K | +51.0% | — |